Current state and perspectives of CAR T cell therapy in central nervous system diseases - Top-Institutions - MDSpire

Current state and perspectives of CAR T cell therapy in central nervous system diseases

  • By

  • Lena Kristina Pfeffer

  • Felix Fischbach

  • Christoph Heesen

  • Manuel A Friese

  • November 12, 2024

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Immunotherapy
    • Neuro-oncology
    • Cellular Therapy

  • #2

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Cellular Immunotherapy
    • Neuroimmunology
    • Neuro-oncology

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Neuro-oncology
    • Cellular Therapy
    • Neuroimmunology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neuroimmunology
    • Cellular Therapy
    • Neurodegenerative Diseases

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neuro-oncology
    • Immunotherapy
    • Cellular Therapy

Original Source(s)

Current state and perspectives of CAR T cell therapy in central nervous system diseases

  • by Lena Kristina Pfeffer, Felix Fischbach, Christoph Heesen, Manuel A Friese

  • November 12, 2024

Related Content

Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD

Non-Linear Measures of Movement Variability in Multiple Sclerosis: A Clinical Narrative Review of Lyapunov Exponent and Entropy Applications in Balance and Gait

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.